ITMI20000788A1 - Nuovo metodo di trattamento - Google Patents

Nuovo metodo di trattamento Download PDF

Info

Publication number
ITMI20000788A1
ITMI20000788A1 IT2000MI000788A ITMI20000788A ITMI20000788A1 IT MI20000788 A1 ITMI20000788 A1 IT MI20000788A1 IT 2000MI000788 A IT2000MI000788 A IT 2000MI000788A IT MI20000788 A ITMI20000788 A IT MI20000788A IT MI20000788 A1 ITMI20000788 A1 IT MI20000788A1
Authority
IT
Italy
Prior art keywords
amoxicillin
release
potassium clavulanate
tablet
formulation
Prior art date
Application number
IT2000MI000788A
Other languages
English (en)
Italian (it)
Inventor
Kevin Storm
Creighton Conley
John Roush
Original Assignee
Beecham Pharmaceuticals Pte Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20000788(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Pharmaceuticals Pte Li filed Critical Beecham Pharmaceuticals Pte Li
Publication of ITMI20000788A0 publication Critical patent/ITMI20000788A0/it
Publication of ITMI20000788A1 publication Critical patent/ITMI20000788A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
IT2000MI000788A 1999-04-13 2000-04-11 Nuovo metodo di trattamento ITMI20000788A1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12907499P 1999-04-13 1999-04-13
US15072799P 1999-08-25 1999-08-25
US15981399P 1999-10-15 1999-10-15

Publications (2)

Publication Number Publication Date
ITMI20000788A0 ITMI20000788A0 (it) 2000-04-11
ITMI20000788A1 true ITMI20000788A1 (it) 2001-10-11

Family

ID=27383840

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000788A ITMI20000788A1 (it) 1999-04-13 2000-04-11 Nuovo metodo di trattamento

Country Status (44)

Country Link
EP (4) EP1044680B1 (enExample)
JP (2) JP4880125B2 (enExample)
KR (1) KR100634937B1 (enExample)
CN (1) CN100382782C (enExample)
AP (1) AP1806A (enExample)
AR (1) AR031068A1 (enExample)
AT (2) ATE242629T1 (enExample)
AU (1) AU767177B2 (enExample)
BE (2) BE1013309A5 (enExample)
BG (1) BG65006B1 (enExample)
BR (1) BRPI0009719B8 (enExample)
CA (1) CA2366304C (enExample)
CO (1) CO5170471A1 (enExample)
CZ (1) CZ298801B6 (enExample)
DE (3) DE60003255T2 (enExample)
DK (3) DK1044680T3 (enExample)
DZ (1) DZ3150A1 (enExample)
EA (1) EA004310B1 (enExample)
ES (2) ES2190692B1 (enExample)
FI (2) FI20000863A7 (enExample)
FR (1) FR2792198A1 (enExample)
GB (1) GB2351661B (enExample)
GR (1) GR1003560B (enExample)
HU (1) HU229097B1 (enExample)
IE (1) IE20000271A1 (enExample)
IL (2) IL145580A0 (enExample)
IT (1) ITMI20000788A1 (enExample)
MA (1) MA25352A1 (enExample)
MX (1) MXPA01010377A (enExample)
MY (1) MY119953A (enExample)
NL (2) NL1014915C2 (enExample)
NO (1) NO329694B1 (enExample)
NZ (1) NZ514575A (enExample)
OA (1) OA11926A (enExample)
PE (1) PE20010053A1 (enExample)
PL (1) PL197448B1 (enExample)
PT (2) PT1044680E (enExample)
RO (1) RO120817B1 (enExample)
SE (1) SE0001330L (enExample)
SI (2) SI1044680T1 (enExample)
SK (1) SK285140B6 (enExample)
TR (1) TR200102963T2 (enExample)
TW (1) TWI235067B (enExample)
WO (1) WO2000061116A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
NZ318282A (en) 1995-09-07 2000-01-28 Smithkline Beecham Corp Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
WO2003004030A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
NZ536267A (en) * 2002-04-10 2007-06-29 Fred H Miller Multi-phase, multi-compartment and multi-ingredient capsular system
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1541129A1 (en) * 2003-12-12 2005-06-15 Cimex AG Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
EP1880716A1 (en) * 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
EP2079453A1 (en) * 2006-10-10 2009-07-22 Penwest Pharmaceuticals Co. Robust sustained release formulations
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
CN107613918B (zh) 2015-04-07 2021-03-09 丘奇和德怀特有限公司 具有硬核的多组分软糖组合物
CN109394718B (zh) * 2018-11-15 2021-04-27 石药集团中诺药业（石家庄）有限公司 一种阿莫西林分散片及其制备方法
CN110051637A (zh) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 阿莫西林克拉维酸钾制剂及其制备方法
US20250312324A1 (en) * 2022-04-29 2025-10-09 Overseas Pharmaceuticals, Ltd. Prolonged-release oral solid formulation of pirfenidone

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
WO1994016696A1 (en) * 1993-01-22 1994-08-04 Smithkline Beecham Plc Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
GB9311030D0 (en) * 1993-05-28 1993-07-14 Smithkline Beecham Corp Pharmaceutical formulations
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
ITMI941169A1 (it) * 1994-06-06 1995-12-06 Smithkline Beecham Farma Formulazioni farmaceutiche
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
NZ318282A (en) * 1995-09-07 2000-01-28 Smithkline Beecham Corp Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
DE69815833T2 (de) * 1997-02-14 2004-05-19 Laboratoire Glaxosmithkline S.A.S. Amoxicillin und clavulanat enthaltende arzneizubereitungen
JP2000510530A (ja) * 1997-03-11 2000-08-15 アルマッグ アル 金属被覆方法、および金属被覆装置
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
ID22340A (id) * 1997-03-25 1999-09-30 Takeda Chemical Industries Ltd Komposisi farmasi lekat-mukosa saluran pencernaan
JP3746901B2 (ja) * 1997-10-15 2006-02-22 ユニ・チャーム株式会社 開閉自在容器
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
GB9818927D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Pharmaceutical formulation
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals

Also Published As

Publication number Publication date
CZ20001311A3 (cs) 2000-11-15
DE10017883A1 (de) 2000-10-26
AP2001002284A0 (en) 2001-12-31
BE1013309A5 (fr) 2001-11-06
NO20001870D0 (no) 2000-04-11
GB2351661B (en) 2001-10-10
AP1806A (en) 2007-12-14
FI20000863L (fi) 2000-10-13
ES2190692B1 (es) 2004-11-16
FI4823U1 (fi) 2001-02-16
DE20006626U1 (de) 2000-10-19
GB2351661A (en) 2001-01-10
FI20000863A7 (fi) 2000-10-13
BG104329A (en) 2001-11-30
GB0008923D0 (en) 2000-05-31
BRPI0009719B8 (pt) 2021-05-25
FI20000863A0 (fi) 2000-04-11
MY119953A (en) 2005-08-30
AT4327U1 (de) 2001-06-25
FR2792198A1 (fr) 2000-10-20
RO120817B1 (ro) 2006-08-30
ES2202004T3 (es) 2004-04-01
ATE242629T1 (de) 2003-06-15
TR200102963T2 (tr) 2002-02-21
AU5702000A (en) 2000-11-14
CN100382782C (zh) 2008-04-23
WO2000061116A2 (en) 2000-10-19
EP1044680A1 (en) 2000-10-18
DK200000133U3 (da) 2000-07-28
NL1014915A1 (nl) 2000-10-16
SE0001330D0 (sv) 2000-04-11
EP1270005A2 (en) 2003-01-02
EP1269996A1 (en) 2003-01-02
BR0009719A (pt) 2002-01-08
IE20000271A1 (en) 2001-04-04
EA004310B1 (ru) 2004-02-26
CO5170471A1 (es) 2002-06-27
BR0009719B1 (pt) 2014-09-30
AU767177B2 (en) 2003-11-06
PT102450A (pt) 2001-02-01
FIU20000164U0 (fi) 2000-04-11
DE60003255D1 (de) 2003-07-17
AR031068A1 (es) 2003-09-10
IL145580A0 (en) 2002-11-10
KR100634937B1 (ko) 2006-10-17
BG65006B1 (bg) 2006-12-29
SI1044680T1 (en) 2003-12-31
NL1014914C1 (nl) 2000-10-16
DK200000602A (da) 2000-10-14
HUP0001471A2 (en) 2001-03-28
HU0001471D0 (en) 2000-06-28
PE20010053A1 (es) 2001-03-10
SE0001330L (sv) 2000-10-14
MXPA01010377A (es) 2002-10-23
SI20304A (sl) 2001-02-28
EP1269997A1 (en) 2003-01-02
TWI235067B (en) 2005-07-01
JP2002541187A (ja) 2002-12-03
DZ3150A1 (fr) 2000-10-19
EP1044680B1 (en) 2003-06-11
NL1014915C2 (nl) 2001-02-12
PL197448B1 (pl) 2008-03-31
SK285140B6 (sk) 2006-07-07
NZ514575A (en) 2004-05-28
JP2011256180A (ja) 2011-12-22
HU229097B1 (en) 2013-07-29
CN1382040A (zh) 2002-11-27
WO2000061116A3 (en) 2001-02-01
CZ298801B6 (cs) 2008-02-06
ITMI20000788A0 (it) 2000-04-11
ES2190692A1 (es) 2003-08-01
BE1012733A6 (fr) 2001-02-06
IL145580A (en) 2007-05-15
GR1003560B (el) 2001-03-16
PT1044680E (pt) 2003-10-31
JP4880125B2 (ja) 2012-02-22
NO329694B1 (no) 2010-12-06
CA2366304C (en) 2004-06-29
PL339591A1 (en) 2000-10-23
CA2366304A1 (en) 2000-10-19
MA25352A1 (fr) 2001-12-31
EP1270005A3 (en) 2006-05-17
SK5342000A3 (en) 2000-11-07
DK1044680T3 (da) 2003-09-29
PT102450B (pt) 2003-09-30
NO20001870L (no) 2000-10-16
DE60003255T2 (de) 2004-05-06
OA11926A (en) 2006-04-12
EA200101075A1 (ru) 2002-04-25
HK1032741A1 (en) 2001-08-03
HUP0001471A3 (en) 2001-10-29
KR20020015312A (ko) 2002-02-27

Similar Documents

Publication Publication Date Title
EP1044680B1 (en) Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
US6660299B2 (en) Modified release pharmaceutical formulation comprising amoxycillin
US7217430B2 (en) Compositions and methods of treatment comprising amoxicillin and potassium clavulanate with xanthan
US6878386B1 (en) Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
HK1052639A (en) Unit dosage comprising amoxicillin and clavulanate
HK1052638A (en) Unit dosage comprising amoxycillin and clavulanate
HK1052640A (en) Formulation comprising amoxicillin and an organic acid
HK1032741B (en) Novel method of treatment using a high dosage regimen of amoxycillin and potassium clavulanate
GB2365337A (en) Amoxycillin and potassium clavulanate high dosage regimen
ZA200108321B (en) Novel method of treatment.